Dolby Laboratories, Inc.
US ˙ NYSE ˙ US25659T1079

SecurityDLB / Dolby Laboratories, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership1,446 shares
Latest Disclosed Value $ 86,847
Strs Ohio reports 0.14% decrease in ownership of DLB / Dolby Laboratories, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 1,446 shares of Dolby Laboratories, Inc. (US:DLB) valued at $86,847 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 1,448 shares of Dolby Laboratories, Inc.. This represents a change in shares of -0.14% during the quarter. The current value of the position is $78,142 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F DOLBY LABORATORIES INCCL A COM_STK 25659T107 1,446 -2 -0.14 87 -6.52 0.0003
2026-02-02 2025-12-31 13F DOLBY LABORATORIES INCCL A COM_STK 25659T107 1,448 2 0.14 93 -11.54 0.0003
2025-10-30 2025-09-30 13F DOLBY LABORATORIES INC-CL A COM_STK 25659T107 1,446 -31,247 -95.58 105 -95.71 0.0004
2025-08-04 2025-06-30 13F DOLBY LABORATORIES INC-CL A COM_STK 25659T107 32,693 7,636 30.47 2,428 20.63 0.0091
2025-05-28 2025-03-31 13F DOLBY LABORATORIES INC-CL A COM_STK 25659T107 25,057 25,057 2,012 0.0084
2024-11-01 2024-09-30 13F DOLBY LABORATORIES INC-CL A COM_STK 25659T107 0 -27,470 -100.00 0 -100.00
2024-08-05 2024-06-30 13F DOLBY LABORATORIES INC-CL A COM_STK 25659T107 27,470 4,339 18.76 2,176 217,500.00 0.0086
2024-05-13 2024-03-31 13F DOLBY LABORATORIES INC-CL A COM_STK 25659T107 23,131 -2,712 -10.49 2 -50.00 0.0077
2024-01-30 2023-12-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 25,843 -2,750 -9.62 2 0.00 0.0093
2023-10-26 2023-09-30 13F/A-1 DOLBY LABORATORIES INC-CL A COM 25659T107 28,593 -1,069 -3.60 2 0.00 0.0101
2023-10-26 2023-09-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 28,593 -1,069 2 0.0101
2023-07-31 2023-06-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 29,662 4,749 19.06 2 0.00 0.0105
2023-08-02 2023-03-31 13F/A-2 DOLBY LABORATORIES INC-CL A COM 25659T107 24,913 -330 -1.31 2 100.00 0.0092
2023-08-02 2023-03-31 13F/A-1 DOLBY LABORATORIES INC-CL A COM 25659T107 24,913 -330 2 0.0092
2023-04-27 2023-03-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 24,913 -330 2 0.0110
2023-01-26 2022-12-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 25,243 1,664 7.06 2 -99.93 0.0080
2022-10-27 2022-09-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 23,579 23,579 1,536 0.0073
2022-01-24 2021-12-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 0 -25,247 -100.00 0 -100.00
2021-10-22 2021-09-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 25,247 1,286 5.37 2,221 -5.69 0.0084
2021-07-26 2021-06-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 23,961 849 3.67 2,355 3.24 0.0085
2021-04-23 2021-03-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 23,112 2,028 9.62 2,281 11.43 0.0086
2021-01-25 2020-12-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 21,084 -9,297 -30.60 2,047 1.69 0.0079
2020-12-14 2020-09-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 30,381 5,782 23.51 2,013 24.26 0.0084
2020-07-23 2020-06-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 24,599 9,442 62.29 1,620 97.32 0.0071
2020-04-23 2020-03-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 15,157 3,146 26.19 821 -0.61 0.0043
2020-01-24 2019-12-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 12,011 5,529 85.30 826 97.61 0.0035
2019-10-21 2019-09-30 13F/A-1 DOLBY LABORATORIES INC-CL A COM 25659T107 6,482 -178 -2.67 418 -2.79 0.0018
2019-10-21 2019-09-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 6,482 -5,529 418 1,850.0912
2019-07-25 2019-06-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 6,660 -82 -1.22 430 1.42 0.0019
2019-04-19 2019-03-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 6,742 -557 -7.63 424 -5.99 0.0019
2019-01-23 2018-12-31 13F DOLBY LABORATORIES INC-CL A COM 25659T107 7,299 -831 -10.22 451 -20.60 0.0023
2018-10-19 2018-09-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 8,130 83 1.03 568 14.52 0.0025
2018-08-06 2018-06-30 13F DOLBY LABORATORIES INC-CL A COM 25659T107 8,047 8,047 496 0.0021
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.